Invited lectures are given by scientists who are world leaders within receptor tyrosine kinase signalling and membrane trafficking.
Among other well-known scientists, The Yale University School of Medicine professor Joseph Schlessinger holds a key note lecture. There also are poster sessions covering the main topics of the meeting. There are 90 participants in the meeting and many of them will either present a short talk or a poster.
Dysregulation of signalling pathways downstream of receptor tyrosine kinases (RTKs) is a frequent event in carcinogenesis. This meeting, the first in a series sponsored by the "Norsk Hydro's Fund" for cancer research, discuss key concepts of RTK signalling pathways, and how such signalling is modulated by intracellular trafficking. Examples of how proper receptor trafficking has a tumour suppressor function are provided, and the mechanisms of intracellular trafficking of RTKs and other receptors are explored. Finally, novel anti-cancer drugs that target RTKs and their pathways are highlighted.
Stalheim 2007 web page (radium.no/stalheim2007)
Department of Biochemistry (radium.no/biochemistry)
Institute for Cancer Research (radium.no/institute)